Similar Articles
251 Hepatocellular carcinoma immune microenvironment and check point inhibitors-current status
252 Lean body mass index is a marker of advanced tumor features in patients with hepatocellular carcinoma
253 Comprehensive prognostic and immune analysis of sterol O-acyltransferase 1 in patients with hepatocellular carcinoma
254 Transarterial chemoembolization plus stent placement for hepatocellular carcinoma with main portal vein tumor thrombosis: A meta-analysis
255 MicroRNAs in hepatocellular carcinoma treatment: Charting the path forward
256 Liver transplantation for hepatocellular carcinoma in India: Are we ready for 2040?
257 Chinese herbal medicine decreases incidence of hepatocellular carcinoma in diabetes mellitus patients with regular insulin management
258 Epidemiology, therapy and outcome of hepatocellular carcinoma between 2010 and 2019 in Piedmont, Italy
259 Risk of cardiovascular death in patients with hepatocellular carcinoma based on the Fine-Gray model
260 Preoperatively predicting vessels encapsulating tumor clusters in hepatocellular carcinoma: Machine learning model based on contrast-enhanced computed tomography
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA